Evidence map›Paper›PMID 33897605›Full record

ArticleFrontiers in neurology2021

Status of Immunotherapy Acceptance in Chinese Patients With Multiple Sclerosis: Analysis of

Ran Zhou, Qiuming Zeng, Huan Yang, Yan Xu, Guojun Tan, Hongbo Liu, Lihua Wang, Hongyu Zhou, Meini Zhang, Jinzhou Feng and 19 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in neurology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. The incidence and prevalence, diagnosis, and treatment of multiple sclerosis in China: a narrative review.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2022
    Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

29 authors.

Ran ZhouDepartment of Neurology, Xiangya Hospital, Central South University, Changsha, China.
Qiuming ZengDepartment of Neurology, Xiangya Hospital, Central South University, Changsha, China.
Huan YangDepartment of Neurology, Xiangya Hospital, Central South University, Changsha, China.
Yan XuDepartment of Neurology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Guojun TanDepartment of Neurology, The Second Hospital of Hebei Medical University, Shijiazhuang, China.
Hongbo LiuDepartment of Neurology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Lihua WangDepartment of Neurology, The Second Affiliated Hospital, Harbin Medical University, Harbin, China.
Hongyu ZhouDepartment of Neurology, West China Hospital, Sichuan University, Chengdu, China.
Meini ZhangDepartment of Neurology, The First Affiliated Hospital of Shanxi Medical University, Taiyuan, China.
Jinzhou FengDepartment of Neurology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Tao JinDepartment of Neurology and Neuroscience Center, The First Hospital of Jilin University, Changchun, China.
Xinghu ZhangDepartment of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Jiawei WangDepartment of Neurology, Beijing Tongren Hospital, Capital Medical University, Beijing, China.
Xu ZhangDepartment of Neurology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Feng GaoDepartment of Neurology, Peking University First Hospital, Beijing, China.
Chunsheng YangDepartment of Neurology, Tianjin Medical University General Hospital, Tianjin, China.
Bitao BuDepartment of Neurology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Chunyang LiDepartment of Neurology, The Affiliated Hospital of Inner Mongolia Medical University, Hohhot, China.
Min ZhangDepartment of Neurology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Huiqing DongDepartment of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China.
Aiyu LinDepartment of Neurology, The First Affiliated Hospital of Fujian Medical University, Fuzhou, China.
Weibin LiuDepartment of Neurology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
Lei WuDepartment of Neurology, General Hospital of the People's Liberation Army, Beijing, China.
Manxia WangDepartment of Neurology, The Second Hospital of Lanzhou University, Lanzhou, China.
Yulan TangDepartment of Neurology, The First Affiliated Hospital, Guangxi Medical University, Nanning, China.
Honghao WangDepartment of Neurology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Youming LongDepartment of Neurology, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
Zhe WangDepartment of Neurology, The First Affiliated Hospital, Dalian Medical University, Dalian, China.
Weihong ZhengDepartment of Neurology, Affiliated Zhongshan Hospital, Xiamen University, Xiamen, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

disease-modifying therapiesdrug selectionimmunosuppressive drugmulticenter studymultiple sclerosis

Identifiers

PMID33897605
PMCPMC8060470

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.